Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Good
|
|
New words:
Abbott, accommodate, America, anticancer, antigen, April, architectural, Biogen, Canada, capture, cumulative, defending, divided, Europe, exceed, expansion, expended, February, FIN, GMP, identification, identity, II, III, immunologic, inaccurate, influence, investigator, lab, launch, learn, lengthy, maintenance, North, occupancy, organization, phase, professional, project, publish, purity, ratably, resource, Rule, scale, site, slightly, staffing, statistical, structural, study, subsidiary, Teva, therefrom, tracking, transferred, turn, understand, unknown, upfront, waive, wrong
Removed:
achieved, amended, attach, Auristatin, average, bladder, breast, Certificate, choose, closed, colon, comprehensive, constructed, developed, disclosed, diverse, ended, evaluated, exhibit, fee, fiscal, hematologic, hematological, holding, insufficient, investing, investor, linker, lung, melanoma, metastatic, offset, opportunity, originally, ovarian, partner, presently, pursuant, registration, release, renal, repeat, retained, scaleable, shared, solid, space, subsequent, synthetic, systemic, Taxotere, toxic, treat, tumor, undergoing, unrealized, vialed
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Amendment to Collaboration Agreement Dated January 9, 2004
- 10.2 Patent Rights Master Agreement and Research License Agreement
- 10.3 Patent License Agreement Dated January 9, 2004
- 10.4 Development and Supply Agreement Dated February 23, 2004
- 31.1 Certification of CEO Pursuant to Rule 13A-14(A)
- 31.2 Certification of CFO Pursuant to Rule 13A-14(A)
- 32.1 Certification of CEO Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification of CFO Pursuant to 18 U.s.c. Section 1350
SGEN similar filings
Filing view
External links
Exhibit 32.2
SEATTLE GENETICS, INC.
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Seattle Genetics, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2004, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tim J. Carroll, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ TIM J. CARROLL |
Tim J. Carroll |
Chief Financial Officer |
May 10, 2004 |